Feynman Point Asset Management launches $300 million cryptocurrency hedge fund
On October 21, according to Forbes, Joe Naggar, former partner at GoldenTree Asset Management under Steven Tananbaum, is launching an independently operated hedge fund with $300 million in assets under management. This marks the official spin-off of his team from Republic, an investment firm focused on cryptocurrencies. Now, Naggar and his team are operating independently under the name Feynman Point Asset Management, an investment firm specializing in the digital asset market and cutting-edge technologies. Despite undergoing several transformations, the fund has continued to perform well. According to Feynman Point Asset Management, since its establishment in 2022, backers including the $600 million Swiss fund L1D and the New York Blockchain Investment Group have achieved an annualized net return of over 42%. Its successful trades include purchasing Grayscale Bitcoin Trust (GBTC) at a 40% discount to its underlying assets, early investment in the high-performing decentralized exchange Hyperliquid, and equity investment in Ripple.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Blackstone (BX.US) injects up to $1.5 billion, providing fresh ammunition for Pfizer (PFE.US) in the weight-loss drug race
Pfizer announced on Wednesday that it has reached an agreement with Blackstone to obtain up to $1.5 billions in funding to support the development of its experimental monthly obesity treatment drug.
Bernstein Downgrades Nvidia Rating and Target Price

Google (GOOGL.US) DeepMind launches AlphaGenome 2: Capable of decoding DNA cells with nearly double the mutation identification capacity
Google DeepMind has released its AI model AlphaGenome 2, which is trained on maps of over 100 millions of cells and has nearly double the ability of its predecessor in identifying gene expression variations.

The White House did not intervene in the decision-making of Nvidia's board of directors.
